Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Paul Liberator"'
Publikováno v:
Frontiers in Microbiology, Vol 11 (2020)
Externí odkaz:
https://doaj.org/article/805e2ecb69e348228a7edcaa05b35cc7
Autor:
Zhenghui Li, Kwok Lee, Urvi Rajyaguru, C. Hal Jones, Sandra Janezic, Maja Rupnik, Annaliesa S. Anderson, Paul Liberator
Publikováno v:
Frontiers in Microbiology, Vol 11 (2020)
Clostridioides (Clostridium) difficile is the most commonly recognized cause of infectious diarrhea in healthcare settings. Currently there is no vaccine to prevent initial or recurrent C. difficile infection (CDI). Two large clostridial toxins, TcdA
Externí odkaz:
https://doaj.org/article/41eb581e31e045218576ad060d1de2e0
Autor:
Robert G. K. Donald, Julio Cesar Hawkins, Li Hao, Paul Liberator, Thomas R. Jones, Shannon L. Harris, John L. Perez, Joseph J. Eiden, Kathrin U. Jansen, Annaliesa S. Anderson
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 2, Pp 255-265 (2017)
Neisseria meningitidis serogroup B (MenB) is an important cause of invasive meningococcal disease. The development of safe and effective vaccines with activity across the diversity of MenB strains has been challenging. While capsular polysaccharide c
Externí odkaz:
https://doaj.org/article/424c89850523457390fe8ba43692f3e3
Autor:
Naglaa Mohamed, Yekaterina Timofeyeva, Dorota Jamrozy, Eduardo Rojas, Li Hao, Natalie C Silmon de Monerri, Julio Hawkins, Guy Singh, Bing Cai, Paul Liberator, Shite Sebastian, Robert G K Donald, Ingrid L Scully, C Hal Jones, C Buddy Creech, Isaac Thomsen, Julian Parkhill, Sharon J Peacock, Kathrin U Jansen, Matthew T G Holden, Annaliesa S Anderson
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0208356 (2019)
Staphylococcus aureus capsular polysaccharides (CP) are important virulence factors under evaluation as vaccine antigens. Clinical S. aureus isolates have the biosynthetic capability to express either CP5 or CP8 and an understanding of the relationsh
Externí odkaz:
https://doaj.org/article/67964ae0bddb44bc9baf0778c2c7d442
Autor:
Wouter Rozemeijer, Pamela Fink, Eduardo Rojas, C Hal Jones, Danka Pavliakova, Peter Giardina, Ellen Murphy, Paul Liberator, Qin Jiang, Douglas Girgenti, Remco P H Peters, Paul H M Savelkoul, Kathrin U Jansen, Annaliesa S Anderson, Jan Kluytmans
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0116945 (2015)
Staphylococcus aureus is a versatile pathogen of medical significance, using multiple virulence factors to cause disease. A prophylactic S. aureus 4-antigen (SA4Ag) vaccine comprising capsular polysaccharide (types 5 and 8) conjugates, clumping facto
Externí odkaz:
https://doaj.org/article/b3d3ac54d8554b799777fbb5dee5bac9
Autor:
Jay R Radke, Robert G Donald, Amy Eibs, Maria E Jerome, Michael S Behnke, Paul Liberator, Michael W White
Publikováno v:
PLoS Pathogens, Vol 2, Iss 10, p e105 (2006)
Toxoplasma is a significant opportunistic pathogen in AIDS, and bradyzoite differentiation is the critical step in the pathogenesis of chronic infection. Bradyzoite development has an apparent tropism for cells and tissues of the central nervous syst
Externí odkaz:
https://doaj.org/article/11c1419a05a2421e9ec98b8e050e18aa
Autor:
Stephen J Thomas, Edson D Moreira, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L Perez, Gonzalo Pérez Marc, Fernando P Polack, Cristiano Zerbini, Ruth Bailey, Kena A Swanson, Xia Xu, Satrajit Roychoudhury, Kenneth Koury, Salim Bouguermouh, Warren V Kalina, David Cooper, Robert W Frenck, Laura L Hammitt, Özlem Türeci, Haylene Nell, Axel Schaefer, Serhat Ünal, Qi Yang, Paul Liberator, Dina B Tresnan, Susan Mather, Philip R Dormitzer, Uğur Şahin, William C Gruber, Kathrin U Jansen
Publikováno v:
Future Virology. 17:849-862
What is this summary about? This is a summary of an article about part of a clinical study for the BNT162b2 COVID-19 vaccine, also called the Pfizer-BioNTech vaccine. The article was published in the New England Journal of Medicine in September 2021.
Autor:
Li Hao, Michelle M. Kuttel, Neil Ravenscroft, Allison Thompson, A. Krishna Prasad, Seema Gangolli, Charles Tan, David Cooper, Wendy Watson, Paul Liberator, Michael W. Pride, Kathrin U. Jansen, Annaliesa S. Anderson, Ingrid L. Scully
Publikováno v:
Vaccine. 40:4872-4880
Protection conferred by pneumococcal polysaccharide conjugate vaccines (PCVs) is associated with PCV-induced antibodies against vaccine-covered serotypes that exhibit functional opsonophagocytic activity (OPA). Structural similarity between capsular
Autor:
Stephen J, Thomas, Edson D, Moreira, Nicholas, Kitchin, Judith, Absalon, Alejandra, Gurtman, Stephen, Lockhart, John L, Perez, Gonzalo, Pérez Marc, Fernando P, Polack, Cristiano, Zerbini, Ruth, Bailey, Kena A, Swanson, Xia, Xu, Satrajit, Roychoudhury, Kenneth, Koury, Salim, Bouguermouh, Warren V, Kalina, David, Cooper, Robert W, Frenck, Laura L, Hammitt, Özlem, Türeci, Haylene, Nell, Axel, Schaefer, Serhat, Ünal, Qi, Yang, Paul, Liberator, Dina B, Tresnan, Susan, Mather, Philip R, Dormitzer, Uğur, Şahin, William C, Gruber, Kathrin U, Jansen
Publikováno v:
The New England Journal of Medicine
Background BNT162b2 is a lipid nanoparticle–formulated, nucleoside-modified RNA vaccine encoding a prefusion-stabilized, membrane-anchored severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) full-length spike protein. BNT162b2 is highly ef
Autor:
Jamie Findlow, Ray Borrow, David S. Stephens, Paul Liberator, Annaliesa S. Anderson, Paul Balmer, Luis Jodar
Publikováno v:
Expert review of vaccines. 21(6)
The two currently licensed surface protein non-capsular meningococcal serogroup B (MenB) vaccines both have the purpose of providing broad coverage against diverse MenB strains. However, the different antigen compositions and approaches used to asses